CD80 and cancer: Lastly, as compared to MIM-SIS adjuvant only, autologous cancer vaccines increased the expression of MHC-II and CD80 by 9-fold (MHC-II + CD80 + cells: 12.45 ± 3.53% vs. 1.33 ± 0.36%; p < 0.001).